Other docking molecules are recruited to IGF1R when activated, such as SHC domain proteins which are mainly involved in the activation of the BRAF/MAPK and the JAK/STATs signaling pathways, both important regulators of tumor progression and immunomodulation (24–27) (Figure 1). Here, IGF1R is linked to neoplasm.